Dr. M. Seth Hochman is a Miami, Florida based neurologist who is specialized in Neurology. Active license number of Dr. M. Seth Hochman is ME22374 for Neurology in Florida. His current practice location is 8600 Sw 92nd St, Galloway Pro Ctr 107, Miami. Patients can reach him at 305-595-7232 or can fax him at 305-595-5967. Dr. M. Seth Hochman is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1346438827. Dr. M. Seth Hochman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. M. Seth Hochman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1346438827
NPI Enumeration Date:
09 Oct, 2007
NPI Last Update On:
04 Nov, 2010
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. M. Seth Hochman are as mentioned below.
License Number
Specialization
State
Status
ME22374
Neurology
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. M. Seth Hochman 8600 Sw 92nd St, Galloway Pro Ctr 107 Miami, Florida
Zip:
33156-7397
Phone Number:
305-595-7232
Fax Number:
305-595-5967
Patients can reach Dr. M. Seth Hochman at 8600 Sw 92nd St, Galloway Pro Ctr 107, Miami, Florida or can call to book an appointment on 305-595-7232.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.